Table 2.
111In-Pentetreotide SPECT/CT scintigraphy and CIP data in 70 GEP tumours with ascertained hepatic, abdominal extra-hepatic and extra-abdominal lesions
| Lesions | Hepatic | Abdominal extra-hepatic | Extraa-bdominal | Total |
|---|---|---|---|---|
| No | 141 | 78 | 73 | 292 |
| CIP Positive | 113 (80.1%) | 40 (51.3%) | 38 (52%) | 191 (65.4%) |
| SPECT/CT Positive | 117 (83%) | 67 (85.9%) | 60 (82.2%) | *244 (83.6%) |
p<0.0001 when compared with corresponding CIP.